Raphaël Schneider

12.4k total citations
54 papers, 961 citations indexed

About

Raphaël Schneider is a scholar working on Pathology and Forensic Medicine, Immunology and Oncology. According to data from OpenAlex, Raphaël Schneider has authored 54 papers receiving a total of 961 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pathology and Forensic Medicine, 15 papers in Immunology and 10 papers in Oncology. Recurrent topics in Raphaël Schneider's work include Multiple Sclerosis Research Studies (19 papers), Peripheral Neuropathies and Disorders (6 papers) and T-cell and B-cell Immunology (6 papers). Raphaël Schneider is often cited by papers focused on Multiple Sclerosis Research Studies (19 papers), Peripheral Neuropathies and Disorders (6 papers) and T-cell and B-cell Immunology (6 papers). Raphaël Schneider collaborates with scholars based in Canada, United Kingdom and United States. Raphaël Schneider's co-authors include Nathalie Arbour, Diane Beauseigle, Jiwon Oh, Paul M. McKeever, Janice Robertson, Anna Karydas, Maria Carmela Tartaglia, Adam L. Boxer, Bruce L. Miller and Alexandre Prat and has published in prestigious journals such as Nature Communications, The Journal of Immunology and Brain.

In The Last Decade

Raphaël Schneider

50 papers receiving 950 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raphaël Schneider Canada 15 302 284 191 181 128 54 961
Begoña Oliver‐Martos Spain 17 287 1.0× 229 0.8× 262 1.4× 188 1.0× 251 2.0× 63 959
Elsebeth Staun-Ram Israel 16 553 1.8× 288 1.0× 264 1.4× 96 0.5× 78 0.6× 22 1.2k
Caterina Veroni Italy 17 334 1.1× 193 0.7× 391 2.0× 205 1.1× 100 0.8× 24 994
Vilija Jokubaitis Australia 17 285 0.9× 177 0.6× 381 2.0× 112 0.6× 104 0.8× 55 816
Federica Esposito Italy 17 169 0.6× 212 0.7× 373 2.0× 72 0.4× 135 1.1× 68 810
Anna Glaser Sweden 22 206 0.7× 530 1.9× 470 2.5× 112 0.6× 221 1.7× 56 1.5k
Rana Zabad United States 16 92 0.3× 137 0.5× 333 1.7× 118 0.7× 166 1.3× 34 722
Ann Dring United Kingdom 15 113 0.4× 351 1.2× 277 1.5× 151 0.8× 296 2.3× 17 865
Alicja Kalinowska Poland 16 138 0.5× 170 0.6× 329 1.7× 95 0.5× 221 1.7× 59 807
Jerome Graber United States 22 155 0.5× 135 0.5× 259 1.4× 180 1.0× 278 2.2× 71 1.4k

Countries citing papers authored by Raphaël Schneider

Since Specialization
Citations

This map shows the geographic impact of Raphaël Schneider's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raphaël Schneider with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raphaël Schneider more than expected).

Fields of papers citing papers by Raphaël Schneider

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raphaël Schneider. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raphaël Schneider. The network helps show where Raphaël Schneider may publish in the future.

Co-authorship network of co-authors of Raphaël Schneider

This figure shows the co-authorship network connecting the top 25 collaborators of Raphaël Schneider. A scholar is included among the top collaborators of Raphaël Schneider based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raphaël Schneider. Raphaël Schneider is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brand‐Arzamendi, Koroboshka, et al.. (2025). Intrathecal interleukin-6 levels are associated with progressive disease and clinical severity in multiple sclerosis. BMC Neurology. 25(1). 136–136. 1 indexed citations
2.
Graham, Simon J., et al.. (2025). Transcranial Photobiomodulation (tPBM) for Mild Cognitive Impairment (MCI): Key Findings from a Pilot Randomized Clinical Trial. Brain stimulation. 18(1). 584–584. 1 indexed citations
3.
Wong, Vincent Kam Wai, Moein Yaqubi, Craig S. Moore, et al.. (2025). Cerebrospinal fluid-driven ependymal motile cilia defects are implicated in multiple sclerosis. Brain.
4.
Suthiphosuwan, Suradech, Jonathan A. Micieli, Reza Vosoughi, et al.. (2024). Low-Field (64 mT) Portable MRI for Rapid Point-of-Care Diagnosis of Dissemination in Space in Patients Presenting with Optic Neuritis. American Journal of Neuroradiology. 45(11). 1819–1825. 5 indexed citations
5.
6.
Schneider, Raphaël, et al.. (2023). Acute central nervous system inflammation following COVID-19 vaccination: An observational cohort study. Multiple Sclerosis Journal. 29(4-5). 595–605. 4 indexed citations
7.
Hubert, Margaux, Laurie Besson, Yenkel Grinberg‐Bleyer, et al.. (2023). MDR1-expressing CD4+ T cells with Th1.17 features resist to neoadjuvant chemotherapy and are associated with breast cancer clinical response. Journal for ImmunoTherapy of Cancer. 11(11). e007733–e007733. 7 indexed citations
8.
Chertcoff, Aníbal, Raphaël Schneider, Christina Azevedo, Nancy L. Sicotte, & Jiwon Oh. (2023). Recent Advances in Diagnostic, Prognostic, and Disease-Monitoring Biomarkers in Multiple Sclerosis. Neurologic Clinics. 42(1). 15–38. 5 indexed citations
9.
Schneider, Raphaël, et al.. (2023). Multiple sclerosis and exercise—A disease-modifying intervention of mice or men?. Frontiers in Neurology. 14. 1190208–1190208. 5 indexed citations
10.
Schneider, Raphaël, et al.. (2022). Acute Central Nervous System Demyelination Following COVID-19 Vaccination. Neurology. 99(23_Supplement_2). 1 indexed citations
11.
Tartour, Kévin, Francesca Andriani, Eric G. Folco, et al.. (2022). Mammalian PERIOD2 regulates H2A.Z incorporation in chromatin to orchestrate circadian negative feedback. Nature Structural & Molecular Biology. 29(6). 549–562. 8 indexed citations
12.
Schneider, Raphaël, Koroboshka Brand‐Arzamendi, Jeffrey Glaister, et al.. (2022). Plasma Neurofilament light levels are increased in people with Radiologically Isolated Syndrome (P1-1.Virtual). Neurology. 98(18_supplement). 1 indexed citations
13.
Morrow, Sarah A., et al.. (2022). Use of natalizumab in persons with multiple sclerosis: 2022 update. Multiple Sclerosis and Related Disorders. 65. 103995–103995. 41 indexed citations
14.
Vosoughi, Amir R., et al.. (2022). Recovery of Vision in Myelin Oligodendrocyte Glycoprotein–IgG Optic Neuritis Without Treatment: A Case Series. Journal of Neuro-Ophthalmology. 43(4). e126–e128. 2 indexed citations
15.
Jones, Ashley, Marika Hohol, Kristen M. Krysko, et al.. (2021). Clinical Characteristics and Outcomes of Multiple Sclerosis Patients with COVID-19 in Toronto, Canada (1556). Neurology. 96(15_supplement). 1 indexed citations
16.
Watt, Jennifer, Zahra Goodarzi, Areti Angeliki Veroniki, et al.. (2021). Comparative efficacy of interventions for reducing symptoms of depression in people with dementia: systematic review and network meta-analysis. BMJ. 372. n532–n532. 69 indexed citations
17.
Lornage, Xavière, Béatrice Lannes, Raphaël Schneider, et al.. (2017). HSPB8 haploinsufficiency causes dominant adult-onset axial and distal myopathy. Acta Neuropathologica. 134(1). 163–165. 24 indexed citations
18.
Schneider, Raphaël. (2014). CD20+ T cells in multiple sclerosis. Multiple Sclerosis and Related Disorders. 4(1). 58–59. 3 indexed citations
19.
Schneider, Raphaël. (2013). Autoantibodies to Potassium Channel KIR4.1 in Multiple Sclerosis. Frontiers in Neurology. 4. 125–125. 2 indexed citations
20.
Schneider, Raphaël, et al.. (2010). IL‐27 increases the proliferation and effector functions of human naïve CD8+ T lymphocytes and promotes their development into Tc1 cells. European Journal of Immunology. 41(1). 47–59. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Begoña Oliver‐Martos Breakdown of academic impact, for papers by Elsebeth Staun-Ram Breakdown of academic impact, for papers by Caterina Veroni Breakdown of academic impact, for papers by Vilija Jokubaitis Breakdown of academic impact, for papers by Federica Esposito Breakdown of academic impact, for papers by Anna Glaser Breakdown of academic impact, for papers by Rana Zabad Breakdown of academic impact, for papers by Ann Dring Breakdown of academic impact, for papers by Alicja Kalinowska Breakdown of academic impact, for papers by Jerome Graber
Rankless by CCL
2026